Skip to content
Riskpilot
← Back to search
Sign in
Get full access
RHINOPHARMA AS
AS
Active
Org 979652461
Karihaugveien 89, 1086
Oslo
Dental practice care activities
·
NACE 8623
Est. 1998 · 28 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Dental practice care activities
/
RHINOPHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−21
−18
−12
−19
−19
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−21
−18
−12
−19
−19
Net financials
−0
0
−0
0
−0
Profit before tax
−21
−18
−12
−19
−19
Tax
−0
−0
−0
−0
−0
Net profit
−21
−18
−12
−19
−19
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
−0
1
7
0
2
Equity
−2 606
−2 624
−2 636
−2 655
−2 674
Long-term debt
2 238
2 238
2 238
2 236
2 235
Short-term debt
368
387
404
419
441
Total debt
2 606
2 625
2 643
2 655
2 676
Financial ratios
5-year trend
EBITDA margin
-1924700.0%
This company
15.8%
Market median
-12181746% vs market
2020
2024
Equity ratio
-134298.9%
This company
38.2%
Market median
-351668% vs market
2020
2024
Return on equity
-1929600.0%
This company
18.4%
Market median
-10487057% vs market
2020
2024
Net profit margin
-1929600.0%
This company
8.1%
Market median
-23822322% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on RHINOPHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network